ESC Premium Access

Circulating levels of ST2 are associated with myocardial injury, left ventricular function and future adverse clinical events in patients with ST-elevation myocardial infarction.

Congress Presentation

About the speaker

Doctor Jan Eritsland

Oslo University Hospital Ulleval, Oslo (Norway)
0 follower

4 more presentations in this session

Circulating serum extracellular matrix degradation enzyme cathepsin S predicts mortality and improves risk stratification over the GRACE score in patients with non-ST elevation acute coronary syndrom

Speaker: Doctor K. Sopova (Mannheim, DE)


Apoptotic and non-apoptotic circulating microparticles in patients with acute coronary syndromes

Speaker: Doctor A. Antonopoulos (Athens, GR)


Results from the CAMI1 Study: Selective CRP apheresis as a new treatment option in acute myocardial infarction

Speaker: Professor C. Garlichs (Flensburg, DE)


HsCRP predicts mortality beyond troponin in 102,337 patients with suspected acute coronary syndrome (CRP-RISK study)

Speaker: Doctor A. Kaura (London, GB)


Access the full session

Non-troponin biomarkers in acute coronary syndromes

Speakers: Doctor J. Eritsland, Doctor K. Sopova, Doctor A. Antonopoulos, Professor C. Garlichs, Doctor A. Kaura

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb